Scleroderma
Updated: 04/18/2006

References

Bonte F, Dumas M, et al. Influence of asiatic acid, madecassic acid, and asiaticoside on human collagen I synthesis. Planta Med. 1994 Apr;60(2):133–5.

Bruckdorfer KR, Hillary JB, et al. Increased susceptibility to oxidation of low-density lipoproteins isolated from patients with systemic sclerosis. Arthritis Rheum. 1995 Aug;38(8):1060–7.

Clements PJ, Seibold JR, et al. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial: Lessons learned. Semin Arthritis Rheum. 2004 Feb;33(4):249–63.

Cotran RS. Diseases of immunity. In: Cotran RS, Kumar V, Collins T, eds. Pathologic Basis of Disease. 6th ed. Philadelphia, Pa: W.B. Saunders; 1999:226–9.

DiGiacomo RA, Kremer JM, et al. Fish-oil dietary supplementation in patients with Raynaud’s phenomenon: A double-blind, controlled, prospective study. Am J Med. 1989 Feb;86(2):158–64.

Engel MF. Dimethyl sulfoxide in the treatment of scleroderma. South Med J. 1972 Jan;65(1):71–3.

Failli P, Palmieri L, et al. Effect of N-acetyl-L-cysteine on peroxynitrite and superoxide anion production of lung alveolar macrophages in systemic sclerosis. Nitric Oxide. 2002 Dec;7(4):277–82.

Furst DE. Rational therapy in the treatment of systemic sclerosis. Curr Opin Rheumatol. 2000 Nov;12(6):540–4.

Furst DE, Clements PJ. D-penicillamine is not an effective treatment in systemic sclerosis. Scand J Rheumatol. 2001;30(4):189–91.

Guseva NG, Starovoitova MN, et al. [Madecassol treatment of systemic and localized scleroderma]. Ter Arkh. 1998;70(5):58–61.

Harada M, Kumemura H, et al. Scleroderma and repeated spontaneous abortions treated with vitamin E: A case report. Kurume Med J. 2005;52(3):93–5.

Herrick AL, Worthington H, et al. Dietary intake of micronutrient antioxidants in relation to blood levels in patients with systemic sclerosis. J Rheumatol. 1996 Apr;23(4):650–3.

Horrobin DF. Essential fatty acid metabolism in diseases of connective tissue with special reference to scleroderma and to Sjogren’s syndrome. Med Hypotheses. 1984 Jul;14(3):233–47.

Horrobin DF. Essential fatty acid and prostaglandin metabolism in Sjogren’s syndrome, systemic sclerosis and rheumatoid arthritis. Scand J Rheumatol Suppl. 1986;61:242–5.

Klyscz T, Rassner G, et al. Biomechanical stimulation therapy: A novel physiotherapy method for systemic sclerosis. Adv Exp Med Biol. 1999;455:309–16.

Krasagakis K, Dippel E, et al. Management of severe scleroderma with long-term extracorporeal photopheresis. Dermatology. 1998;196(3):309–15.

Maquart FX, Chastang F, et al. Triterpenes from Centella asiatica stimulate extracellular matrix accumulation in rat experimental wounds. Eur J Dermatol. 1999 Jun;9(4):289–96.

Mayes MD. The establishment and utility of a population-based registry to understand the epidemiology of systemic sclerosis. Curr Rheumatol Rep. 2000 Dec;2(6):512–6.

Mayes MD. Scleroderma epidemiology. Rheum Dis Clin North Am. 2003 May;29(2):239–54.

Mayes MD, Lacey JV Jr, et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum. 2003 Aug;48(8):2246–55.

Salsano F, Letizia C, et al. Significant changes of peripheral perfusion and plasma adrenomedullin levels in N-acetylcysteine long term treatment of patients with sclerodermic Raynauds phenomenon. Int J Immunopathol Pharmacol. 2005 Oct-Dec;18(4):761–70.

Scherbel AL. The effect of percutaneous dimethyl sulfoxide on cutaneous manifestations of systemic sclerosis. Ann N Y Acad Sci. 1983;411:120–30.

Sommerburg O, et al. Enhanced lipid peroxidation in systemic scleroderma. Z Dermatol. 1996;182(3):124, 126–8.

Todisco M. Effectiveness of a treatment based on melatonin in five patients with systemic sclerosis. Am J Ther. 2006 Jan-Feb;13(1):84–7.

Widgerow AD, Chait LA, et al. New innovations in scar management. Aesthetic Plast Surg. 2000 May;24(3):227–34.

Williams HJ, Furst DE, et al. Double-blind, multicenter controlled trial comparing topical dimethyl sulfoxide and normal saline for treatment of hand ulcers in patients with systemic sclerosis. Arthritis Rheum. 1985 Mar;28(3):308–14.

Zic JA, Miller JL, et al. The North American experience with photopheresis. Ther Apher. 1999 Feb;3(1):50–62.